公司新闻 - 亚科因（Abbkine）—服务于细胞和蛋白研究全球用户

公司新闻 - 亚科因（Abbkine）—服务于细胞和蛋白研究全球用户

首页
技术中心
产品文献

或

货号	产品名称	文献标题	IF	杂志名称
A23220	山羊抗兔IgG二抗，绿色DyLight 488荧光标记	Daidzein attenuates hepatic ischemia/reperfusion injury via HMGB1-TLR4 signaling pathway	2.800	Toxicon
A23220	山羊抗兔IgG二抗，绿色DyLight 488荧光标记	Pomegranate-inspired bionic microgel/periosteum composite harnessing reactive oxygen species for immune-engineered bone regeneration	12.400	Journal of Controlled Release
A23220	山羊抗兔IgG二抗，绿色DyLight 488荧光标记	Withaferin-A induces apoptosis and autophagy in colorectal cancer cell lines via down-regulated expression of histone deacetylase 1.	0	Investigación Clínica
A23220	山羊抗兔IgG二抗，绿色DyLight 488荧光标记	Loss of Pericyte Exacerbates Alzheimer's Disease‐Associated Retinal Pathology	5	Clinical & Experimental Ophthalmology
A23220	山羊抗兔IgG二抗，绿色DyLight 488荧光标记	Pyridoxal Reprograms Peroxisomal Hydrogen Peroxide Metabolism to Induce Lethal Oxidative Stress in Ovarian Cancer	/	iMetaMed
A23220	山羊抗兔IgG二抗，绿色DyLight 488荧光标记	YY1/Asprosin/PFKP axis regulates glycolytic metabolic and exacerbates pathological cardiac hypertrophy	18.100	Nature Communications
A23220	山羊抗兔IgG二抗，绿色DyLight 488荧光标记	Immune Checkpoint Activity and Prognostic Roles of TNFRSF8, CD160, and TNFSF9 in Primary and Brain Metastatic NSCLC	2.100	Asia-Pacific Journal of Clinical Oncology
A23220	山羊抗兔IgG二抗，绿色DyLight 488荧光标记	Antagonistic SUMOylation and Ubiquitination of ACSL4 Control Ferroptosis in Colorectal Cancer	/	/
A23220	山羊抗兔IgG二抗，绿色DyLight 488荧光标记	Astragaloside IV confers vascular protection after traumatic brain injury through an Nrf2-dependent mechanism involving VWF	2.900	IBRO Neuroscience Reports
A23220	山羊抗兔IgG二抗，绿色DyLight 488荧光标记	Histone H4 lysine 5 Lactylation: A Key Regulator of Immune Metabolism in Microglia During Ischemic Stroke	12.200	Pharmacological Research

首页上一页 103 104 105 106 107 108 下一页尾页

赋能细胞研究与治疗 Enabling cell research and therapy

联系我们

全国服务热线： 400-6800-830

订购邮箱： service@abbkine.com

联系地址：武汉光谷生物医药加速器17号楼1号房2-3层

友情链接：

Copyright ©Abbkine Scientific Co., Ltd- 鄂ICP备10204150号-5

意见反馈

 在线咨询

扫码关注

微信公众号

返回顶部